Onconetix Statistics
Share Statistics
Onconetix has 8.29M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 8.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 89 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 33.33K, so 0.4% of the outstanding shares have been sold short.
| Short Interest | 33.33K |
| Short % of Shares Out | 0.4% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 0.45 |
Valuation Ratios
The PE ratio is -3.62 and the forward PE ratio is -2.07.
| PE Ratio | -3.62 |
| Forward PE | -2.07 |
| PS Ratio | 2318 |
| Forward PS | 100.3 |
| PB Ratio | 2.31 |
| P/FCF Ratio | -9.94 |
| PEG Ratio | n/a |
Enterprise Valuation
Onconetix Inc. has an Enterprise Value (EV) of 8.72M.
| EV / Earnings | -0.23 |
| EV / Sales | 149.14 |
| EV / EBITDA | -0.24 |
| EV / EBIT | -0.24 |
| EV / FCF | -0.64 |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.34 |
| Quick Ratio | 0.32 |
| Debt / Equity | 0.17 |
| Total Debt / Capitalization | 14.33 |
| Cash Flow / Debt | -1.38 |
| Interest Coverage | -53.65 |
Financial Efficiency
Return on equity (ROE) is -0.64% and return on capital (ROIC) is -47.7%.
| Return on Equity (ROE) | -0.64% |
| Return on Assets (ROA) | -0.43% |
| Return on Capital (ROIC) | -47.7% |
| Revenue Per Employee | 4.87K |
| Profits Per Employee | -3.12M |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | 3.26 |
Taxes
| Income Tax | -12.59K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -90.94% in the last 52 weeks. The beta is 3.73, so Onconetix 's price volatility has been higher than the market average.
| Beta | 3.73 |
| 52-Week Price Change | -90.94% |
| 50-Day Moving Average | 1.31 |
| 200-Day Moving Average | 4.66 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 5.35M |
Income Statement
In the last 12 months, Onconetix had revenue of 58.47K and earned -37.41M in profits. Earnings per share was -2.19.
| Revenue | 58.47K |
| Gross Profit | -1.13M |
| Operating Income | -36.03M |
| Net Income | -37.41M |
| EBITDA | -36.71M |
| EBIT | -36.03M |
| Earnings Per Share (EPS) | -2.19 |
Balance Sheet
The company has 4.55M in cash and 9.89M in debt, giving a net cash position of -5.33M.
| Cash & Cash Equivalents | 4.55M |
| Total Debt | 9.89M |
| Net Cash | -5.33M |
| Retained Earnings | -56.79M |
| Total Assets | 61.92M |
| Working Capital | -16.31M |
Cash Flow
In the last 12 months, operating cash flow was -13.58M and capital expenditures -55.04K, giving a free cash flow of -13.64M.
| Operating Cash Flow | -13.58M |
| Capital Expenditures | -55.04K |
| Free Cash Flow | -13.64M |
| FCF Per Share | -0.8 |
Margins
Gross margin is -192.79K%, with operating and profit margins of -6.16M% and -6.40M%.
| Gross Margin | -192.79K% |
| Operating Margin | -6.16M% |
| Pretax Margin | -6.40M% |
| Profit Margin | -6.40M% |
| EBITDA Margin | -62.78K% |
| EBIT Margin | -61.63K% |
| FCF Margin | -23.32K% |
Dividends & Yields
ONCO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -308.45% |
| FCF Yield | -232.62% |
Analyst Forecast
Currently there are no analyst rating for ONCO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 24, 2024. It was a backward split with a ratio of 1:40.
| Last Split Date | Sep 24, 2024 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | -4.84 |
| Piotroski F-Score | 4 |